Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3zrm | ZRM | Glycogen synthase kinase-3 beta | 2.7.11.26 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3zrm | ZRM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 1.000 | |
3zrk | ZRK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.694 | |
4acd | GR9 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.631 | |
3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.619 | |
3f7z | 34O | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.615 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.599 | |
3zrl | ZRL | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.592 | |
3gb2 | G3B | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.584 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.581 | |
4j71 | 1JX | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.580 | |
3sd0 | TSK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.577 | |
1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.568 | |
2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.565 | |
4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.565 | |
4j1r | I5R | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.565 | |
1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.562 | |
4b7t | CWT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.562 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.560 | |
3du8 | 553 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.556 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.550 | |
4nm0 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.549 | |
4nm7 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.549 | |
3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.542 | |
4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.542 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.537 | |
1r0e | DFN | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.528 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.528 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.527 | |
3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.527 | |
1j1b | ANP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.522 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.522 | |
2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.522 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.521 | |
3eb0 | DRK | Uncharacterized protein | / | 0.519 | |
3f88 | 3HT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.518 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.517 | |
1uv5 | BRW | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.515 | |
1q4l | 679 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.511 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.508 | |
1pyx | ANP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.508 | |
4nm5 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.507 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.505 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.505 | |
4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.505 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.501 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.499 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.499 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.497 | |
2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.496 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.494 | |
2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.494 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.493 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.490 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.488 | |
3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.488 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.488 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.487 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.486 | |
4wbo | ANW | Rhodopsin kinase | / | 0.486 | |
2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.485 | |
3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.485 | |
1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.484 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.484 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.484 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.484 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.484 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.483 | |
4qmy | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.483 | |
2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.482 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.482 | |
4fsm | HK1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.482 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.482 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.481 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.481 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.480 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.479 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.479 | |
3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.479 | |
2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.478 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.477 | |
3cxw | 7CP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.477 | |
1nxk | STU | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.476 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.475 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.474 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.474 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.474 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.474 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.472 | |
4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
1ykd | CMP | Adenylate cyclase | / | 0.471 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.471 | |
2oh0 | 2PY | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.471 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.471 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.471 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.471 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.470 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.470 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.470 | |
4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 | 0.470 | |
4wsq | KSA | AP2-associated protein kinase 1 | 2.7.11.1 | 0.470 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.468 | |
3kkv | B99 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.468 | |
4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
4oac | ADP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.468 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.466 | |
3blr | CPB | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.466 | |
3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.466 | |
3zdu | 38R | Cyclin-dependent kinase-like 3 | 2.7.11.22 | 0.466 | |
2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
4ix6 | ADP | Uncharacterized protein | / | 0.464 | |
4l9i | 8PR | Rhodopsin kinase | / | 0.464 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.464 | |
2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.463 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.463 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.463 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.463 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.463 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.463 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.463 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.463 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.462 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.462 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.462 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.462 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.461 | |
4fyn | 0VE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.461 | |
4hyh | 1AM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
4hyi | 1AO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
4w9w | YDJ | BMP-2-inducible protein kinase | 2.7.11.1 | 0.461 | |
5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.461 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.460 | |
2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.459 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
1pjc | NAD | Alanine dehydrogenase | / | 0.458 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.458 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
2wip | P49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.458 | |
3ag9 | A02 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.458 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.458 | |
4jik | 1KO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
2uxh | QUE | HTH-type transcriptional regulator TtgR | / | 0.457 | |
2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
3pjc | PJC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.457 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.457 | |
4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.457 | |
4ks7 | X4Z | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.457 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
3oqk | S52 | Renin | 3.4.23.15 | 0.456 | |
5cu6 | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.456 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.455 | |
3pe2 | E1B | Casein kinase II subunit alpha | 2.7.11.1 | 0.455 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.455 | |
2f7e | 2EA | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.454 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.454 | |
3c4x | ATP | Rhodopsin kinase | / | 0.454 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
3tuc | FPW | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.454 | |
4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.454 | |
4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.453 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
2ojj | 82A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.453 | |
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.453 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.453 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.453 | |
2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.452 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.452 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.452 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.452 | |
4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.452 | |
4lm5 | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.451 | |
2ojf | 4PY | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.451 | |
2uw0 | GVK | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.451 | |
3l9n | L9N | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.451 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.451 | |
4i41 | MIX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.451 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.451 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.451 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
2hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.450 | |
2uxu | NAR | HTH-type transcriptional regulator TtgR | / | 0.450 | |
2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2yyi | FAD | 4-hydroxyphenylacetate 3-monooxygenase oxygenase component | 1.14.14.9 | 0.450 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.450 | |
4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.450 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.449 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.449 | |
2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.449 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.449 | |
3hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.449 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.449 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.449 | |
4n6h | EJ4 | Delta-type opioid receptor | / | 0.449 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.448 | |
2gnf | Y27 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.448 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
2pmn | K51 | Protein kinase 7 | / | 0.448 | |
2uzu | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.448 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.448 | |
3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.448 | |
3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.448 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.448 | |
1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.447 | |
1pye | PM1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
2c27 | ACO | Mycothiol acetyltransferase | 2.3.1.189 | 0.447 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.447 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.447 | |
3ibq | ATP | Pyridoxal kinase | / | 0.447 | |
3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.447 | |
4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.447 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.447 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.447 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.446 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
2xj1 | XJ1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.446 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.446 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.445 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
2pan | FAD | Glyoxylate carboligase | 4.1.1.47 | 0.445 | |
2vtt | LZD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
3blq | ATP | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.445 | |
3vbq | 0F5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.445 | |
4fl2 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.445 | |
4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.445 | |
5auv | AGI | Death-associated protein kinase 1 | 2.7.11.1 | 0.445 | |
1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.444 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.444 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.444 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
2vuw | 5ID | Serine/threonine-protein kinase haspin | 2.7.11.1 | 0.444 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
2gpv | OHT | Estrogen-related receptor gamma | / | 0.443 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.443 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.443 | |
3nup | 3NU | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.443 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.443 | |
3r7u | X96 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3u9e | COA | Lmo1369 protein | / | 0.443 | |
3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.443 | |
4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.443 | |
4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.443 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.443 | |
1hk3 | T44 | Serum albumin | / | 0.442 | |
1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.442 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.442 | |
2f7x | 4EA | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
2gdo | 12C | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
2gna | GDU | UDP-N-acetylglucosamine 4,6-dehydratase (inverting) | 4.2.1.115 | 0.442 | |
3l9m | L9M | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.442 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.442 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.442 | |
4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.442 | |
1ia3 | TQ5 | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.441 | |
2uxp | CLM | HTH-type transcriptional regulator TtgR | / | 0.441 | |
2wmv | ZYV | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3c4e | C4E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
3l9l | L9L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
3own | 3OW | Renin | 3.4.23.15 | 0.441 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
4czt | CPS | CBL-interacting serine/threonine-protein kinase 23 | 2.7.11.1 | 0.441 | |
4erk | OLO | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
4f07 | FAD | Styrene monooxygenase component 2 | / | 0.441 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.441 | |
4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.441 | |
4zir | ANP | Energy-coupling factor transporter ATP-binding protein EcfA2 | 3.6.3 | 0.441 | |
4zir | ANP | Energy-coupling factor transporter ATP-binding protein EcfA1 | / | 0.441 | |
2uzt | SS3 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.440 | |
2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.440 | |
3iae | D7K | Benzaldehyde lyase | / | 0.440 | |
3oqf | S51 | Renin | 3.4.23.15 | 0.440 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.440 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.440 | |
5dgz | L20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.440 |